Effects of interferon on growth rate and radiation sensitivity of cultured, human glioma cells. 1982

T Nederman, and G Benediktsson

The influence of interferon (IFN) on the growth rate and on the radiation sensitivity of 2 human tumour cell lines was investigated. The 2 glioma cell lines (U-118 MG and U-251 MG) were continuously exposed to IFN (100 U/ml) in the culture medium. Irradiation (3 Gy) was performed either on the first day of IF treatment or on day 14 of IFN treatment. The growth delay induced by the treatments was analysed. The results indicated that IFN had an anti-proliferative effect on the 2 cell lines. However, this effect declined during the treatment and after 2 to 3 weeks of continuous IFN treatment, both cell lines had re-established their original growth rate. IFN did not seem to affect the sensitivity of the cells to radiation. Only an additive effect could be observed.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D011836 Radiation Tolerance The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Sensitivity,Radiosensitivity,Sensitivity, Radiation,Tolerance, Radiation,Radiation Sensitivities,Radiation Tolerances,Radiosensitivities,Sensitivities, Radiation,Tolerances, Radiation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

T Nederman, and G Benediktsson
October 1976, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
T Nederman, and G Benediktsson
October 1977, Radiology,
T Nederman, and G Benediktsson
December 1990, Journal of neuro-oncology,
T Nederman, and G Benediktsson
January 1980, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
T Nederman, and G Benediktsson
March 1988, Journal of neuropathology and experimental neurology,
T Nederman, and G Benediktsson
January 1981, Acta radiologica. Oncology,
T Nederman, and G Benediktsson
January 1988, Cancer letters,
T Nederman, and G Benediktsson
August 2003, Cancer biotherapy & radiopharmaceuticals,
Copied contents to your clipboard!